Leadership Team
New leadership with an amazing track record of growth and successful exits like other leading healthcare organizations.
Deborah Dean
Chief Government & Strategic Growth Officer
View Bio
Ashley Reynolds, PhD, MSN, RN
Chief Product & Experience Officer
View Bio
Kyle Caple
Chief Sales Officer
View Bio
Robby Booth
Founder & Chief Strategy Officer
View Bio
Jordan Messler, MD, SFHM, FACP
Chief Medical Officer
View Bio
Board of Directors
Patrick F. Cua
President & CEO
Mr. Cua has more than 30 years of healthcare leadership experience, ranging from large Fortune 500 companies to startups focused on solutions for consumers, hospitals, health plans, government entities, and Fortune 1000 employers. Mr. Cua’s industry experience began with C.R. Bard and has included executive positions with CorSolutions, Matria Healthcare, Alere, and Aetna.
Mr. Cua played key roles ranging from Chairman to Senior Executive in the sale of CorSolutions to Matria , Matria to Inverness, and Pihms to Aetna. He recently helped lead the successful sale of BioIQ to the Ireland-based company, LetsGetChecked, as the Executive Chairman of the Board.
Cua has built, chaired, and served on a number of boards as an NACD certified director. He currently serves on the boards of high growth healthcare technology companies, including Gozio Health in Atlanta and Glytec Systems in Boston.
Matt McPherson
Chief Financial Officer
Mr. McPherson has more than 20 years of leadership in healthcare and energy sectors helping organizations scale using data and analytics to enable informed decision making. Mr. McPherson develops and organizes financial performance metrics to translate company objectives to actual performance and actionable intelligence across entire organizations.
A seasoned executive, McPherson also led and built Operations, Business Performance and Quality teams and has a broad understanding of a company’s need for upstream workflows and operational execution standards required to produce desired downstream financial results and shareholder value.
Mr. McPherson worked as Controller with a healthcare technology company in Western Pennsylvania, Pihms, raising debt and equity resulting ultimately in the acquisition by Aetna in 2012. Prior to that he served as a financial analyst at Equitable Resources, an energy company governed by the Public Utilities Commission (PUC) and grew a recurring revenue consumer retail entity from inception to profitability inside two years. Most recently, following a 500% growth in revenues over the final three years at BioIQ, McPherson as CFO led the deal team in a successful acquisition of BioIQ by Let’sGetChecked.
Native of Pittsburgh, Pennsylvania McPherson earned a bachelor’s degree in Accounting at Robert Morris University and currently resides in Florida with his wife and three dogs. He has donated his spare time outside of work to canine related causes at the Children’s Hospital of Pittsburgh Cancer Center Therapy Dog (“Pet Friends”) program and his wife Michelle is a certified dog trainer at Pets for Vets, adopting and training dogs for donation to military veterans in need.
Erik Eaker
Chief Operating Officer
Earlier in his career, Eaker served in a variety of leadership roles at Humana, a US health and wellbeing company. He established and managed operations for Humana’s London-based start-up, Humana Europe, an NHS commissioning services provider that commercialized new payer capabilities with over 50 NHS organization customers.
At Humana US, he directed multiple enterprise-wide initiatives to successfully promote cross-business innovation, enrich consumer and provider experiences, and in his last role, established the enterprise’s interoperability strategy. Erik led operations and innovative programming with national foundations, nonprofits, and academic institutions to support Humana’s Bold Goal population health initiative. He led consumer experience and business planning for its incentivized wellness platform and employer group segment and developed groundbreaking digital and communication capabilities. Most recently, Erik was SVP of Business Operations at Let’s Get Checked, a virtual care company that offers at-home testing, telehealth services, and pharmacy capabilities.
Let’s Get Checked acquired BioIQ in 2022 where Erik was SVP of Business Operations and responsible for account and client success management, supply chain management, and customer service functions. During his final 2 years at BioIQ, Erik was part of the executive that grew revenue by over 500% and achieved profitability while maintaining the same headcount and shifting to a remote workforce.
Deborah Dean
Chief Government & Strategic Growth Officer
Deborah Dean is a highly respected technology executive with more than 25 years’ experience in the healthcare industry and extensive C-level expertise in operations, technology, data integration, analytics, applications development, informatics and technical infrastructure. Most recently she served as Chief Analytics and Technology Officer at BioIQ (acquired by Let’s Get Checked), a healthcare engagement and gap closure company that is redefining the way payers, employers and consumers navigate and connect with the U.S. healthcare system.
Deborah has served as Executive Vice President at MiMedx, President and Chief Operating Officer at HolaDoctor, Executive Vice President and Chief Technology officer at Matria Healthcare, and Senior Vice President of Research at Quovadx, Inc. (now Lawson software). In 2008, she received the prestigious CIO of the Year Award from the Georgia CIO Leadership Association. Deborah holds a bachelor’s degree in health services administration from Arkansas State University.
Ashley Reynolds, PhD, MSN, RN
Chief Product & Experience Officer
C-suite executive with demonstrated record of high growth success growth including executive leadership in health technology startups leading to successful exits. Previous roles include CEO, COO, and CXO.
Expert in digital health and the use of technology to promote health and patient engagement.
Developed multiple award-winning digital health applications for population health (CES Mobile App Showdown Winner, CTIA Hot for the Holidays Finalist, CTIA emerging technology awards – First Place, Digital Health Awards – Gold).
Senior executive with decades of experience leading large regional territories and multiple departments within health technology, population health, disease management, health plan, and wellness companies.
In-depth knowledge of (Disease Management, Health Plan, HEDIS & Wellness and Health Promotion) NCQA accreditation, Health Quality, and FDA medical device standards.
Over 30 years in healthcare with over 20 years as a professional nurse and healthcare leader in a variety of settings.
Ashley is an expert in e-health and digital health technologies as tools for behavior change, as well as the age-related differences in their adoption. He has published on the effectiveness of virtual coaches to reduce health risks and promote engagement. He is a frequent speaker on health, wellness, technology-mediated health behavior, and the use of digital coaching tools to improve health and has guided the development of awarding-winning mobile health applications. He is a frequent peer reviewer on the topic of technology and health for the Society for Behavioral Medicine and is a member of the American College of Sports medicine and the Patient Experience Institute. He holds bachelor’s and master’s degrees in nursing administration from Jacksonville University, and a PhD in nursing specializing in digital health behavior from the University of Florida.
Kyle Caple
Chief Sales Officer
As the Senior Vice President of Sales Kyle is responsible for leading, growing, and building the Glytec Sales Organization. In this role Kyle is responsible for increasing both the number of organizations that utilize Glytec’s eGMS solutions, as well as Glytec’s revenue growth.
Kyle joins Glytec with a 20 plus year track record of success in Healthcare software and services companies, including Cerner, T System, and PeraHealth. Kyle lives in Gunter, TX near Dallas with his wife Christin, son Brooks and daughter Berkeley.
Robby Booth
Founder & Chief Strategy Officer
Robby Booth is the Founder and Chief Strategy Officer at Glytec, where he guides the company’s strategic vision and development of innovative technologies. He is an inventor of over one hundred pending and granted U.S. and international patents, co-author of numerous scientific abstracts and clinical publications, and has led regulatory strategy for the company’s multiple FDA clearances.
He holds a Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professionals Society and is a Certified Professional in Healthcare Quality (CPHQ) from the National Association for Healthcare Quality. He holds a Bachelor of Science in Business Studies and International Management from Southern New Hampshire University, and Master of Business Administration from the Darla Moore School of Business at the University of South Carolina.
Jordan Messler, MD, SFHM, FACP
Chief Medical Officer
Jordan Messler, MD, SFHM, FACP is the Chief Medical Officer with Glytec. He trained in internal medicine at Emory University in Atlanta, and subsequently served as an academic hospitalist at Emory University for several years after residency.
He is the former medical director for the Morton Plant Hospitalist group in Clearwater, Florida (serving BayCare Health), where he continues to work as a hospitalist.
He is the current physician editor for the Society of Hospital Medicine’s (SHM) blog, The Hospital Leader. In addition, he previously chaired SHM’s Quality and Patient Safety Committee and has been active in several of their national mentoring programs, including Project BOOST and Glycemic Control.
He has talked at national conferences on a variety of topics such as teamwork in the hospital, quality and patient safety, the history of hospitals and mentoring quality improvement projects.
Luis Simonet
Chief Information Security Officer, CISO
Luis is a seasoned Cyber Security, IT, and Compliance professional with over 20 years of experience. His expertise lies in ensuring robust security measures, enhancing business processes, safeguarding data privacy, adhering to regulatory compliance, and implementing effective IT controls. Throughout his career, Luis has demonstrated proficiency in managing compliance and regulatory frameworks across various industries, including HIPAA, HITRUST, ISO 27001, PCI DSS, FFIEC, and NIST. He specializes in the management of sensitive data, data loss prevention, cyber security, identity management, and data privacy. Luis has a proven track record of driving success and implementing key controls and best practices. His strategic methodologies in IT operations, information security, and risk management have been highly effective in mitigating risks and enhancing organizational security.
Dave Cooper
VP of Implementation Management
Dave Cooper, BSN, RN, serves as the Vice President of Implementation Management, where he is at the forefront of assisting hospitals clinical transformation through Glytec’s cutting-edge technological solutions. With his nursing background and over 8 years of experience in implementing Glytec’s eGlycemic Management system in dozens of hospitals across the country, Dave has an extensive history of facilitating successful clinical practice change that drives better outcomes.
Dave’s journey began as a Registered Nurse in a large ICU. His interest in technology, problem-solving and leadership led to him taking on various super user roles and becoming a Supervisor in the ICU. During his time in the ICU, he was a user of Glytec’s Glucommander insulin dosing software and saw how it improved clinical workflows and let to superior patient outcomes.
In his current role, Dave leads cross-functional teams in the successful deployment of Glytec’s eGlycemic Management System. As a leader, Dave has a track record of fostering a culture of innovation and process improvement. His hands on, process driven approach and mentorship have cultivated teams that are both highly skilled and highly motivated to deliver experiences that exceed customer expectations.
In addition to having a Bachelor’s of Science in Nursing from Clemson University, Dave has completed the Diabetes Educator Level 1 Career Path Certificate Program. He resides in Greenville, South Carolina with his wife and 4 children.
Shirley Stoker
VP of Finance
Shirley Stoker is a seasoned financial executive and CPA with more than 30 years of financial experience. With expertise spanning middle market private equity backed companies, public companies, and public accounting, Shirley has consistently delivered meaningful results through her ability to streamline and scale operations for growth, implement robust internal controls, and optimize financial reporting systems.
Most recently as Controller at BioIQ , Shirley implemented cash management and financial reporting processes during a period of record growth to drive profitability and cash flows. As CFO for Theragenics Corporation, Shirley performed due diligence for potential acquisitions and successfully integrated acquired companies. She also orchestrated the successful international expansion into Costa Rica and Ireland establishing financial reporting structures and ensuring compliance with legal requirements. Shirley started her career in public accounting and was an audit manager at Grant Thornton LLP. A trusted advisor and collaborator, Shirley is known for her attention to detail and commitment to ethical practice. She holds a Master of Accountancy and a BBA in Finance (graduating Magna Cum Laude) from the University of Georgia.
Shelley Brown
VP of Clinical Management
Shelley Brown is a registered nurse and the VP of Clinical Management at Glytec. Shelley has almost 20 years of experience working with Glucommander. Prior to joining Glytec in 2013, Shelley was a bedside nurse and Clinical Educator in the cardiovascular stepdown unit at Greenville Memorial Hospital where she used Glucommander for 7 years. She also served as the Diabetes Liaison Nurse for her unit. Shelley holds a bachelor’s degree from Clemson University.
Betsy Kubacka, DNP, MSN, RN, AGPCNP-BC, RDN, CDCES
VP of Clinical Strategy
Beata (Betsy) Kubacka, DNP, MSN, RN, AGPCNP-BC, RDN, CDCES, serves as Glytec’s Vice President of Clinical Strategy. Betsy first obtained a Bachelor’s in Dietetics and Nutrition. She later received her nursing degree, two Master of Science degrees with a focus in Nursing Education and Gerontological / Adult Nurse Practitioner, and most recently obtained her Doctorate in Nursing Practice, focusing on Leadership and Innovation. In addition to her role with Glytec, Betsy continues to care for patients as an Endocrine nurse practitioner with Hartford HealthCare and co-leads the system initiative for Diabetes clinical care redesign. Before joining Glytec, Betsy served as Hartford HealthCare’s Endocrine Council Co-Chair, where she led the implementation of Glucommander software as the clinical project lead for the health system. She is known for her expertise in hyperglycemic emergencies and inpatient glycemic management and has been published in various peer-reviewed journals, including Nursing Critical Care. Betsy brings a wealth of knowledge in healthcare, with over 25 years of combined inpatient, outpatient, and healthcare technology experience.
Hannah Day
VP of Clinical Strategy
Hannah Day is a healthcare professional with over 15 years of experience in diabetes management as an RN Certified Diabetes Care and Education Specialist (CDCES) and Nurse Practitioner, certified in Advanced Diabetes Management (BC-ADM). Hannah’s passion is for improving diabetes care across the care continuum through quality improvement initiatives and program development and optimization. Prior to joining Glytec, Hannah has served in multiple clinical and leadership roles at Northeast Georgia Health System. Most recently, she served as Diabetes Program Manager and Administrative Director for Hospital Medicine where she led initiatives such as Glucommander IV implementation, Epic quality dashboard builds and Inpatient Glycemic Team development.
Rachel Hoffman
Director of Quality & Regulatory
Rachel is an experienced leader with over a decade of experience in quality assurance and regulatory affairs within the healthcare industry. Currently serving as the Director of Quality and Regulatory at Glytec, Rachel brings a wealth of expertise in design control, quality systems, and regulatory compliance. Prior to her role at Glytec, she excelled as the Postmarket & Quality Systems Lead at ConvergeHEALTH by Deloitte and as the VP of Technical Services at UltraLinq Healthcare Solutions, Inc. Her career journey showcases her proficiency in managing distributed teams, developing robust quality processes, and driving continuous improvement initiatives. With a Bachelor of Science in Health Information Management from CUNY School of Professional Studies, Rachel is equipped with the knowledge and skills to navigate complex regulatory landscapes and ensure the highest standards of product quality and safety.
Andrew R. Midler
Mr. Midler serves as Managing Member at Savitr Capital, LLC which has its primary focus in health care venture investments. Mr. Midler founded the firm in 2008. Previously, Mr. Midler served as Chief Executive Officer and Chief Investment Officer at Standard Pacific Capital. From 1986 to 1993, he worked as a Portfolio Manager at Fidelity Investments. Mr. Midler holds an MBA from Harvard Business School. He earned MA and BA degrees in political science from Stanford University.
Bruce W. Bode, MD
Dr. Bode is a diabetologist and head of research at Atlanta Diabetes Associates, an NCQA-accredited physician practice and research organization specializing in the care of people with diabetes and endocrine disorders. He is also a clinical associate professor of medicine at Emory University School of Medicine. Dr. Bode is considered one of the world’s leading experts in insulin delivery and glucose sensing and is very active in clinical research on new diabetes products, including pharmacological agents, insulins, and glucose sensors. He is a member of the JDRF international research team validating the efficacy and safety of real-time continuous glucose monitoring and is a member and former president of the American Diabetes Association Georgia Chapter. Dr. Bode has written more than 200 articles, abstracts, books and book chapters in the field of diabetes and served as editor of the American Medical Association’s 2004 edition of Medical Management of Type 1 Diabetes. He also serves on the advisory boards of many leading companies in the field of diabetes care and research. Dr. Bode received a doctorate degree from Emory University School of Medicine, completed an internship and residency at Emory University Affiliated Hospitals and a fellowship in diabetes with Dr. Paul C. Davidson.
